Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Borderline Resectable Pancreatic Adenocarcinoma
Hangzhou, Zhejiang
Borderline Resectable Pancreatic Adenocarcinoma Clinical Trials in Hangzhou, Zhejiang
1 recruiting
Hangzhou, Zhejiang, China
Showing
1–1
of
1
trials
Recruiting
Phase 2
HRS-4642 in Combination With Nimotuzumab and Chemotherapy for BRPC With KRAS G12D Mutation
Borderline Resectable Pancreatic Adenocarcinoma
Zhejiang University
40 enrolled
2 locations
NCT07240766
Feedback